 Strides Pharma Science Ltd consolidated Q2FY26 net profit climbs to Rs. 127.53 crores
Strides Pharma Science Ltd consolidated Q2FY26 net profit climbs to Rs. 127.53 crores ASI Industries Ltd Q2FY26 profit at Rs. 81.30 lakhs
ASI Industries Ltd Q2FY26 profit at Rs. 81.30 lakhs Jubilant Pharmova Ltd consolidated Q2FY26 net profit rises to Rs. 120.3 crores
Jubilant Pharmova Ltd consolidated Q2FY26 net profit rises to Rs. 120.3 crores Bharat Electronics Ltd Q2 FY2025-26 consolidated profit at Rs. 1287.77 crores
Bharat Electronics Ltd Q2 FY2025-26 consolidated profit at Rs. 1287.77 crores ACC Ltd consolidated Q2 FY2026 PAT zooms to Rs. 1119.23 crores
ACC Ltd consolidated Q2 FY2026 PAT zooms to Rs. 1119.23 crores 
              The trustees of Sundaram BNP Paribas Mutual Fund have approved July 31, 2009 as the record date for declaration of 20% dividend under the dividend option of Sundaram BNP Paribas S.M.I.L.E Fund (Small and Medium Indian Leading Equities Fund).
Accordingly dividend will be paid to all the unitholders whose names appear on the Register of investors/unitholders of the schemes, on July 31, 2009 subject to availability of distributable surplus under the scheme.
The Face Value of Mutual Fund units are Rs 10 and the dividend declared is 20% or Rs 2.0 per unit.
The NAV (Net Asset Value) of Sundaram BNP Paribas S.M.I.L.E Fund was Rs 13.5202 on July 24, 2009. It should be noted that pursuant to payment of dividend, the NAV of the scheme would fall to the extent of dividend payout and statutory levy if any.
Past performance may or may not be sustained in the future and should not be used as a basis of comparison with other investments.
Mutual Funds and Securities Investments are subject to market risks and there is no assurance or guarantee that the objectives of the scheme will be achieved. Please read the scheme information documents / addendums of the schemes carefully before investing.